S.BrcicL.et al (2013)
Gallbladder disease, including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), has been reported with GLP-1 receptor agonists as a class
Confirm vial strength: Because dosing is by total blend, your unit count depends on whether the vial is 20 mg or 10 mg total check the label before every cycle
3), suggesting that these metabolites may be a feature of glaucoma with uncontrollable IOP
While the vial dries, draw the recommended amount of bacteriostatic water into your sterile syringe according to your pharmacist's instructionstypically this creates a concentration that allows for flexible dosing
The rationale is that glucagon also increases energy expenditure and promotes hepatic fat mobilization, so a molecule that combines glucagons metabolic-rate effect with GLP-1/GIPs appetite-and-glucose control can, in principle, drive weight loss from both sides of the energy-balance equation at once